|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 09, 2022 06:29PM
|
|
Re: Eversana ValuationCaseStudy
|
11
|
Resverlogix Corp.
|
Jan 08, 2022 12:52PM
|
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
8
|
Resverlogix Corp.
|
Jan 08, 2022 12:20PM
|
|
Re: Long term risks associated with covid
|
6
|
Resverlogix Corp.
|
Jan 06, 2022 12:23PM
|
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
5
|
Resverlogix Corp.
|
Jan 05, 2022 01:38PM
|
|
Re: Eversana ValuationCaseStudy
|
3
|
Resverlogix Corp.
|
Jan 04, 2022 01:16PM
|
|
Re: As we finish another brutal year as retail shareholders....
|
7
|
Resverlogix Corp.
|
Dec 30, 2021 10:26AM
|
|
Snow Job
|
1
|
Resverlogix Corp.
|
Dec 22, 2021 01:18PM
|
|
Re: Momentum Players and Agoracom.com’s Rules
|
6
|
Resverlogix Corp.
|
Dec 21, 2021 11:22AM
|
|
Re: Momentum Players and Agoracom.com’s Rules
|
14
|
Resverlogix Corp.
|
Dec 20, 2021 01:32PM
|
|
Re: Risk vs Reward moving forward!
|
9
|
Resverlogix Corp.
|
Dec 17, 2021 05:28PM
|
|
Re: Update
|
6
|
Resverlogix Corp.
|
Dec 17, 2021 12:28PM
|
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
7
|
Resverlogix Corp.
|
Dec 14, 2021 05:39PM
|
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
4
|
Resverlogix Corp.
|
Dec 14, 2021 12:30PM
|
|
Re: Form 45-106F1 Report of Exempt Distribution Dec 13, 2021
|
4
|
Resverlogix Corp.
|
Dec 14, 2021 09:34AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
2
|
Resverlogix Corp.
|
Dec 13, 2021 12:46PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
8
|
Resverlogix Corp.
|
Dec 13, 2021 11:55AM
|
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 12, 2021 05:23PM
|
|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 11, 2021 01:39PM
|
|
Re: Question for posters
|
6
|
Resverlogix Corp.
|
Dec 11, 2021 01:27PM
|
